Будь ласка, використовуйте цей ідентифікатор, щоб цитувати або посилатися на цей матеріал:
http://ir.librarynmu.com/handle/123456789/2943
Повний запис метаданих
Поле DC | Значення | Мова |
---|---|---|
dc.contributor.author | Arych, M. | - |
dc.contributor.author | Arych, H. | - |
dc.contributor.author | Levon, M. | - |
dc.contributor.author | Ulynych, Y. | - |
dc.date.accessioned | 2022-06-15T16:32:20Z | - |
dc.date.available | 2022-06-15T16:32:20Z | - |
dc.date.issued | 2021-09 | - |
dc.identifier.citation | ONLINE JOURNAL MODELLING THE NEW EUROPE | uk_UA |
dc.identifier.issn | 2247-0514 | - |
dc.identifier.uri | http://ir.librarynmu.com/handle/123456789/2943 | - |
dc.description.abstract | The purpose of the research study is to investigate the implications peculiarities of genetic testing in insurance for non-EU insurance markets as a part of the European integration process. The research model was developed by reviewing the previous studies in the area of genetic testing in insurance. Also, it was applying the correlation-regression analysis for defining the relationship between the causes of death and life insurance market competitiveness in the context of genetic testing in insurance implications for non-EU insurance markets as a part of the European integration process. The originality of the study is explained by the fact that it was described the genetic testing in insurance implications for non-EU insurance markets as a part of the European integration process; secondly, for the first time was conducted the correlation-regression analysis of the interconnection of causes of death and life insurance market competitiveness (case study of Ukrainian insurance market) in the context of genetic testing in insurance implications for non-EU insurance markets as a part of the European integration process). The scientific value of the research results also is explained vie the possibility of apply these findings for start to regulate the using of the genetic testing for risk assessment at the Ukrainian life insurance market and in others European countries that are not members of the EU and in EU countries that do not have any specific regulations in the area of applying genetic testing technologies for risk assessment in insurance | uk_UA |
dc.language.iso | en | uk_UA |
dc.publisher | ONLINE JOURNAL MODELLING THE NEW EUROPE | uk_UA |
dc.relation.ispartofseries | 36; | - |
dc.subject | insurance | uk_UA |
dc.subject | genetic testing | uk_UA |
dc.subject | genetic discrimination | uk_UA |
dc.subject | European Union | uk_UA |
dc.subject | integration | uk_UA |
dc.subject | human rights protection | uk_UA |
dc.title | Genetic testing in insurance: implications for non-eu insurance markets as a part of the european integration process | uk_UA |
dc.type | Article | uk_UA |
Розташовується у зібраннях: | Наукові публікації кафедри описової та клінічної анатомії |
Файли цього матеріалу:
Файл | Опис | Розмір | Формат | |
---|---|---|---|---|
Левон М._Scopus_2.pdf | 1,21 MB | Adobe PDF | Переглянути/Відкрити |
Усі матеріали в архіві електронних ресурсів захищені авторським правом, всі права збережені.